Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors

NCT02455596 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors

Interventions

DRUG: Recombinant anti-tumor and anti-virus protein for injection (Novaferon)

Sponsor

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences